Alembic Pharmaceuticals Limited (APLLTD.BO)
BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹770.95 (+0.50%) as of
Key statistics
- Market cap
- 151.54B
- P/E (TTM)
- 21.86
- Forward P/E
- 15.75
- EPS (TTM)
- 35.27
- Dividend yield
- 1.56%
- 52-week range
- 635.30 – 998.00
- Beta
- 0.32
- Revenue (TTM)
- 77.84B
- Profit margin
- 8.91%
- Analyst target
- ₹961.80
- Volume
- 5.54k
About Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal health; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Vadodara, India
- Employees
- 17,244
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.